Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense Industry News February 15, 2022 …
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron Medical Countermeasures February 10, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
First Lethal Hamster Model for SARS-CoV-2 Developed by USAMRIID Scientists Medical Countermeasures February 4, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
Three Doses of mRNA COVID-19 Vaccines Effective Against Hospitalizations for Omicron and Delta Medical Countermeasures January 21, 2022 …
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy Medical Countermeasures December 16, 2021 …
Biodefense and Countering Disease with Neutralizing Antibodies Medical Countermeasures December 15, 2021 …
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule Defense + Military December 8, 2021 …
Does AstraZeneca’s COVID Vaccine Give Longer-Lasting Protection Than mRNA Shots? Medical Countermeasures December 4, 2021 …
Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development Medical Countermeasures November 18, 2021 …
JPEO-CBRND Seeks Prototype Proposals for Vaccine Acceleration Program Contracts + Grants November 15, 2021 …
Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray Industry News November 9, 2021 …
Nose Sprays, Needle-Free Patches, Durable Immunity: Towards the Next Generation of COVID Vaccines Medical Countermeasures November 8, 2021 …
Vaccination Offers Higher Protection Than Previous COVID-19 Infection Medical Countermeasures October 29, 2021 …
A Pediatrician Explains How Pfizer’s Covid-19 Vaccine for Ages 5 to 11 Was Tested for Safety and Efficacy Medical Countermeasures October 29, 2021 …
Rwanda and Senegal Will Host Africa’s First COVID-19 Vaccine Manufacturing Plants Industry News October 27, 2021 …
